236 related articles for article (PubMed ID: 20197555)
1. Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.
Bolli N; Payne EM; Grabher C; Lee JS; Johnston AB; Falini B; Kanki JP; Look AT
Blood; 2010 Apr; 115(16):3329-40. PubMed ID: 20197555
[TBL] [Abstract][Full Text] [Related]
2. Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development.
Barbieri E; Deflorian G; Pezzimenti F; Valli D; Saia M; Meani N; Gruszka AM; Alcalay M
Oncotarget; 2016 Aug; 7(34):55302-55312. PubMed ID: 27486814
[TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model.
Cheng K; Sportoletti P; Ito K; Clohessy JG; Teruya-Feldstein J; Kutok JL; Pandolfi PP
Blood; 2010 Apr; 115(16):3341-5. PubMed ID: 19666870
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
6. Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.
Garcia JS; Huang M; Medeiros BC; Mitchell BS
Clin Cancer Res; 2016 Apr; 22(8):1978-88. PubMed ID: 26634271
[TBL] [Abstract][Full Text] [Related]
7. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
8. Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML.
Payne EM; Bolli N; Rhodes J; Abdel-Wahab OI; Levine R; Hedvat CV; Stone R; Khanna-Gupta A; Sun H; Kanki JP; Gazda HT; Beggs AH; Cotter FE; Look AT
Blood; 2011 Jul; 118(4):903-15. PubMed ID: 21653321
[TBL] [Abstract][Full Text] [Related]
9. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance.
Alcalay M; Tiacci E; Bergomas R; Bigerna B; Venturini E; Minardi SP; Meani N; Diverio D; Bernard L; Tizzoni L; Volorio S; Luzi L; Colombo E; Lo Coco F; Mecucci C; Falini B; Pelicci PG
Blood; 2005 Aug; 106(3):899-902. PubMed ID: 15831697
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
12. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia.
Oelschlaegel U; Koch S; Mohr B; Schaich M; Falini B; Ehninger G; Thiede C
Leukemia; 2010 Oct; 24(10):1813-6. PubMed ID: 20724983
[No Abstract] [Full Text] [Related]
13. A knock-in Npm1 mutation in mice results in myeloproliferation and implies a perturbation in hematopoietic microenvironment.
Chou SH; Ko BS; Chiou JS; Hsu YC; Tsai MH; Chiu YC; Yu IS; Lin SW; Hou HA; Kuo YY; Lin HM; Wu MF; Chou WC; Tien HF
PLoS One; 2012; 7(11):e49769. PubMed ID: 23226219
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
15. The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model.
Sportoletti P; Varasano E; Rossi R; Bereshchenko O; Cecchini D; Gionfriddo I; Bolli N; Tiacci E; Intermesoli T; Zanghì P; Masciulli A; Martelli MP; Falzetti F; Martelli MF; Falini B
Blood; 2013 Apr; 121(17):3447-58. PubMed ID: 23435463
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.
Zhang W; Zhao C; Zhao J; Zhu Y; Weng X; Chen Q; Sun H; Mi JQ; Li J; Zhu J; Chen Z; Pandolfi PP; Chen S; Yan X; Xu J
Theranostics; 2018; 8(16):4359-4371. PubMed ID: 30214626
[TBL] [Abstract][Full Text] [Related]
17. XPO1 is a new target of homoharringtonine (HHT): Making NPMc
Xue J; Chu P; Gao W; Wang F; Gao Y; Liu S; Kang Z; Yan J; Wang H
Biochem Biophys Res Commun; 2023 Oct; 675():155-161. PubMed ID: 37473530
[TBL] [Abstract][Full Text] [Related]
18. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
[TBL] [Abstract][Full Text] [Related]
19. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
20. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]